FDA approves Tanovea first lymphoma drug for dogs

Basit Awan

Cancers are bad for people. They're also pretty damn awful for the dogs, too

Dogs suffer from cancer just like people do, and it's pretty awful for them. The FDA has approved the first drug that will help treat lymphoma in dogs, which is a type of cancer that can be extremely difficult to treat in humans as well. This new treatment option is great news for dogs with this condition.

A canine cancer that affects fewer than 70,000 dogs in the U.S., but accounts for up to 24% of all cancers among canines is considered one of the most significant types because it has such a profound impact on its victims.

Canine lymphoma may not have as many cases annually when compared with other dog diseases, like heart disease and diabetes which affect more than 500 thousand dogs each year respectively; however this particular type still poses an immense risk to pets who are unlucky enough to be diagnosed with it since they face significantly greater challenges recovering from treatment relative their counterparts suffering from another illness without any accompanying complications or symptoms related specifically towards them.

It is well documented that veterinarians are some of the most passionate people in society, but they still have to deal with all sorts of crazy animals. In a recent study conducted by Tanovea on dog lymphoma patients and their reactions to various treatments, it was found that out of 158 dogs who received either Tanovea or placebo treatment for a year: 120 were treated with Tanovea while 38 had no involvement at all. The age range from 1-15 years old (120) vs 3-16 years old (38). Dogs can be as young as one and up until 15 when given this medication!

The FDA has warned pet owners to be careful about the possible adverse events and side effects before giving their dogs any medication, including potential allergic reactions. They must also provide them with a "client information sheet" that details all of the risks associated with taking such drugs so they can make an informed decision on whether or not it is worth risking life-threatening symptoms for what may only yield temporary relief from minor problems.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

Comments / 0

Published by

I am pharmacist and blogger who loves giving information about the latest medical inventions and ailments to his audience. I have written articles on the recent covid 19 scandal in pharmaceuticals, which he found interesting because of its implication in modern medicine.

New Jersey State

More from Basit Awan

Comments / 0